Doç. Dr. Tülay Eren

Doctor and researcher Ankara Etlik Şehir Hastanesi Ankara
Stomach NeoplasmsLung NeoplasmsNeoplasmsColorectal NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell LungTesticular NeoplasmsRectal NeoplasmsCOVID-19Liver Neoplasms
Open institution page
Suggest a correction

Is this your profile? Claim it and verify your details.

Claim profile

Person ↔ Disease

Which diseases does this doctor work on?

From source
  • Stomach Neoplasms 5 publications
    Source: OpenAlex / PubMed MeSHView publications
  • Lung Neoplasms 4 publications
  • Neoplasms 4 publications
  • Colorectal Neoplasms 4 publications
  • Breast Neoplasms 3 publications
  • Carcinoma, Non-Small-Cell Lung 2 publications
  • Testicular Neoplasms 2 publications
  • Rectal Neoplasms 2 publications
  • COVID-19 2 publications
  • Liver Neoplasms 2 publications

Trust

Where does this information come from?

The source is stated next to each piece of information. If you see something wrong, you can suggest a correction.

  • Department name at the sourceOnkolojisaglik.gov.trFrom source
  • InstitutionAnkara Etlik Şehir Hastanesisaglik.gov.trFrom source
  • Area of workStomach NeoplasmsExtracted from 5 publications · Model version —From source
  • Publications80 publicationsOpenAlex, Europe PMC, ORCIDFrom source
  • ORCID0000-0002-0088-1149ORCIDFrom source
  • Last synchronised7 November 2026 00:02https://etliksehir.saglik.gov.tr/TR-864408/klinik-doktorlarimiz.html#tulay-erensaglik.gov.tr

Scientific work

Publications on Stomach Neoplasms

80 publications

  1. Real-World Outcomes of CDK4/6 Inhibitors in Germline BRCA1/2-Mutated Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Turkish Oncology Group (TOG) Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33060365 PMID 42346265 Open-access full textSource: OpenAlex

  2. Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis

    Journal of Clinical Medicine, 2026

    DOI 10.3390/jcm15072475 PMID 41976774 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  3. Fear of Cancer Recurrence and Psychological Symptom Burden in Breast Cancer Survivors Without Evidence of Active Disease: A Cross-Sectional Real-World Study

    Healthcare (Basel, Switzerland), 2026

    DOI 10.3390/healthcare14162665 PMID 42651434 Open-access full textSource: Europe PMC

  4. Prognostic Significance of Lung Immune Prognostic Index at Diagnosis in Stage III Non-Small Cell Lung Cancer

    Current oncology (Toronto, Ont.), 2026

    DOI 10.3390/curroncol33010043 PMID 41590363 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  5. Association Between Smoking Status and PD-L1 Expression in Metastatic Driver Mutation Negative Non-Small Cell Lung Cancer: A Real-World Cohort Study

    Eurasian Journal of Medical Investigation, 2026

    DOI 10.14744/ejmi.2612473 Source: OpenAlex

  6. Independent factors associated with advanced testicular germ cell tumors: the roles of smoking, lymphovascular invasion, and tumor size

    BMC Cancer, 2026

    DOI 10.1186/s12885-026-15598-y PMID 41555284 Open-access full textSource: OpenAlex

  7. Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study

    Current Oncology, 2026

    DOI 10.3390/curroncol33090526 PMID 42782872 Open-access full textSource: OpenAlex

  8. Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study

    Cancer Investigation, 2025

    DOI 10.1080/07357907.2025.2595536 PMID 41347635 1 citation (Europe PMC) Source: OpenAlex

  9. Could Sarcopenia Be Related to Chemotherapy in Gastrointestinal Cancer? A Cross-Sectional Study Including Comprehensive Geriatric Assessment

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm14030711 PMID 39941382 4 citations (Europe PMC) Open-access full textSource: ORCID

  10. Prognostic Value of STAS, Lymph Node Metastasis, and VPI in NSCLC ≤ 4 cm Treated with Lobectomy

    Journal of Clinical Medicine, 2025

    DOI 10.3390/jcm15010233 PMID 41517482 Open-access full textSource: OpenAlex

View all 80 publications